New York Hospital / Cornell University Medical Center Laboratory of Urological Oncology

What's New

October 17, 2000: Phase I trial of humanized mAb huJ591-DOTA-90Yttrium to Prostate Specific Membrane Antigen in patients with recurrent/relapsed Prostate Cancer begins.

Questions or comments about these web pages? Send e-mail.

PreviousHomeNext